L-glutamate dehydrogenase mutant and application thereof
AssigneeAbiochem Biotechnology Co., Ltd.
InventorsZhenhua Tian, Zhanbing Cheng, Shaonan Ding, Qi Jiao, Wenxuan Xu, Yao Huang, Feng Jiang
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbiochem Biotechnology Co., Ltd.
InventorsZhenhua Tian, Zhanbing Cheng, Shaonan Ding, Qi Jiao, Wenxuan Xu, Yao Huang, Feng Jiang
Estimating the term…
Disclosed in the present invention is an L-glutamate dehydrogenase mutant, the sequence of the L-glutamate dehydrogenase mutant being a sequence in which amino acid residue A at position 175 in SEQ ID NO: 1 is mutated to be G, and amino acid residue V at position 386 is mutated to be an amino acid residue having less steric hindrance. Further disclosed in the present invention is an application of the described L-amino acid dehydrogenase mutant in the preparation of L-glufosinate-ammonium or a salt thereof. When the L-glutamate dehydrogenase mutant of the present invention is used to prepare L-glufosinate-ammonium or a salt thereof, compared to an L-glutamate dehydrogenase mutant in which only position 175 or 386 is mutated, the specific enzyme activity is higher. Therefore, the action efficiency of the enzyme is improved, reaction costs are reduced, and industrial production is facilitated.
An L-glutamate dehydrogenase mutant, wherein the L-glutamate dehydrogenase mutant has a sequence obtained by mutating amino acid residue A at position 175 of SEQ ID NO:
A method for preparing an L-glufosinate salt, comprising:
(canceled)
A composition comprising 2-oxo-4-(hydroxymethyl phosphinyl) butyric acid, L-glufosinate and D-glufosinate, wherein 2-oxo-4-(hydroxymethyl phosphinyl) butyric acid is more than 40% (in mole) of the total amount of L-glufosinate, D-glufosinate and 2-oxo-4-(hydroxymethyl phosphinyl) butyric acid.
Dependencies are inferred from the claim text.